scanX
Home
Albert David

Albert David

1,475.00
+15.35
(1.05%)
Market Cap (₹ Cr.)
₹822
52 Week High
1,753.95
Book Value
₹
52 Week Low
726.30
PE Ratio
11.61
PB Ratio
2.15
PE for Sector
38.21
PB for Sector
4.52
ROE
%
ROCE
77.25 %
Dividend Yield
0.79 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
17.66 %
Net Income Growth
108.49 %
Cash Flow Change
332.51 %
ROE
69.61 %
ROCE
79.80 %
EBITDA Margin (Avg.)
48.57 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
72
85
95
74
111
81
94
60
73
56
93
78
71
96
79
87
71
93
91
83
61
59
75
70
61
86
92
78
74
88
106
82
81
110
105
105
100
112
Expenses
61
77
82
70
62
73
79
59
62
66
78
71
57
82
76
73
58
78
77
73
62
58
60
60
50
71
73
64
64
81
78
66
72
79
77
80
79
88
EBITDA
11
8
13
4
49
8
14
1
11
-10
15
8
14
14
3
14
13
15
14
10
-1
0
14
11
11
15
19
13
9
7
28
16
10
31
28
25
20
24
Operating Profit %
13 %
9 %
13 %
5 %
9 %
8 %
13 %
-0 %
12 %
-21 %
15 %
5 %
17 %
13 %
3 %
6 %
15 %
15 %
14 %
8 %
-4 %
-8 %
16 %
9 %
12 %
13 %
15 %
10 %
13 %
13 %
15 %
11 %
12 %
14 %
17 %
9 %
11 %
1 %
Depreciation
4
2
2
2
2
2
2
2
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
2
2
2
Interest
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
6
5
11
1
46
6
12
-1
9
-12
13
5
11
12
1
12
11
13
12
8
-4
-2
12
8
9
13
16
11
7
4
26
14
7
29
27
23
18
22
Tax
2
2
4
6
2
2
5
-0
3
0
3
2
4
5
1
2
4
4
4
2
0
0
1
2
2
3
4
2
3
4
5
3
4
4
5
4
4
1
Net Profit
4
3
6
-5
44
3
7
-1
7
-8
8
4
6
8
0
11
7
9
8
5
-3
-1
10
6
7
10
13
8
4
2
20
11
4
23
20
19
13
19
EPS in ₹
7.11
4.89
11.20
-9.03
77.03
5.80
12.42
-1.86
11.60
-14.56
14.62
7.05
10.12
13.74
0.72
19.24
12.99
16.28
13.88
9.20
-5.78
-1.86
17.16
10.72
12.78
18.30
22.20
13.96
7.31
3.08
35.29
18.48
6.54
41.16
35.57
32.80
22.63
33.02
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
193
224
285
290
295
320
341
401
423
498
Fixed Assets
49
44
87
83
77
91
84
88
80
83
Current Assets
117
152
164
172
186
201
223
253
304
372
Capital Work in Progress
5
5
9
5
5
2
1
1
3
7
Investments
0
31
59
68
113
122
138
183
193
273
Other Assets
139
143
130
134
99
106
119
130
148
135
Total Liabilities
101
87
102
104
84
97
97
122
112
115
Current Liabilities
84
75
88
89
68
81
81
107
99
99
Non Current Liabilities
17
12
13
14
16
16
16
14
13
16
Total Equity
93
137
183
186
210
223
244
279
312
383
Reserve & Surplus
87
131
177
180
205
217
239
274
306
377
Share Capital
6
6
6
6
6
6
6
6
6
6
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
12
-10
15
-4
0
-2
-1
-1
4
Investing Activities
-9
-38
-36
-11
-19
-20
-37
-40
-5
-33
Operating Activities
28
68
20
30
32
30
37
40
11
46
Financing Activities
-18
-18
7
-5
-17
-10
-2
-2
-6
-8
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
61.25 %
61.25 %
61.35 %
61.64 %
61.96 %
61.99 %
61.99 %
61.99 %
62.04 %
62.04 %
62.04 %
62.04 %
62.13 %
62.13 %
FIIs
0.00 %
0.00 %
0.50 %
0.71 %
0.75 %
0.64 %
0.61 %
0.57 %
0.57 %
0.65 %
0.57 %
0.70 %
0.98 %
0.80 %
DIIs
3.81 %
3.53 %
3.18 %
3.18 %
3.18 %
3.18 %
2.98 %
2.84 %
2.80 %
2.30 %
1.90 %
1.67 %
1.67 %
1.67 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
34.94 %
35.22 %
34.97 %
34.47 %
34.11 %
34.19 %
34.42 %
34.59 %
34.59 %
35.01 %
35.48 %
35.59 %
35.22 %
35.40 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,857.50 4,43,025.22 42.01 49,887.17 12.06 9,648 42.62 63.32
Cipla
1,637.30 1,32,315.81 29.77 26,520.66 14.17 4,155 17.77 55.49
Dr Reddys Laboratories
6,561.00 1,08,578.89 19.51 28,905.40 12.36 5,578 -0.90 33.11
Zydus Life Science
1,054.95 1,06,092.28 25.45 19,831.50 13.82 3,831 30.78 29.67
Lupin
2,152.60 98,990.94 43.74 20,141.50 19.94 1,936 77.69 50.58
Mankind Pharma
2,520.70 97,396.59 49.63 10,615.63 19.57 1,942 9.89 55.98
Aurobindo Pharma
1,500.00 89,493.33 24.95 29,559.25 17.55 3,169 61.17 52.33
Alkem Laboratories
6,154.85 73,392.58 34.14 12,978.42 9.84 1,811 91.18 56.16
Glenmark Pharmaceuticals
1,649.70 46,593.50 - 12,653.09 6.58 -1,831 96.52 48.98
Biocon
363.60 43,311.65 27.75 15,621.20 35.25 1,298 478.78 47.25

Corporate Action

Technical Indicators

RSI(14)
Neutral
48.14
ATR(14)
Volatile
70.78
STOCH(9,6)
Oversold
10.50
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-23.73
ADX(14)
Weak Trend
24.94
UO(9)
Bearish
34.34
ROC(12)
Downtrend But Slowing Down
-12.29
WillR(14)
Oversold
-85.81
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.